Phys Vivas · infectious
Bone AND Joint Infections — Viva Defence
DCE viva defence for Bone AND Joint Infections.
On this page
Study tools
Target exams
Bone AND Joint Infections Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Bone AND Joint Infections. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
References6ShowHide
- [1]Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis, 2015.PMID 26229122
- [2]Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis, 2013.PMID 23223583
- [3]Mathews CJ, Weston VC, Jones A, et al. Bacterial septic arthritis in adults. Lancet, 2010.PMID 20206778
- [4]Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis, 2012.PMID 22619242
- [5]Li HK, Rombach I, Zambellas R, et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection. N Engl J Med, 2019.PMID 30699315
- [6]Mitrovic S, Delplanque M, Ea HK, Frémond ML, et al. Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update Joint Bone Spine, 2026.PMID 42276158